EVgo: Likely Won't Be Cash Flow Positive Until 2031, Yet Appears To Be A Great Long-Term Investment

EVgo stands out by focusing on DCFC charging, decoupling revenue growth from EV sales. Read why I am bullish about EVGO stock right now.
The Lancet

From prediction to navigation for artificial intelligence in medicine

Whether estimating the probability that a disease is present or forecasting risk of deterioration,1 readmission,2 or death,3 most contemporary clinical artificial intelligence (AI) systems are ...
News-Medical.Net

Delaying hepatitis B birth vaccines increases infant infection risks

Delaying hepatitis B vaccination after birth increases infections among newborns and decreases their survival rates and ...
BMJ Global Health

Postpartum continuity of care for women with HIV: Option B+ policy impact and limitations in South Africa

Introduction Postpartum disengagement from HIV care increases risks for adverse maternal health outcomes and transmission of ...